Pharmacogenetics: UGT1A, NAT2, TPMT, and OATP1B1 Insights

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/26

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

27 Terms

1
New cards

What does the UGT1A gene locus encode?

The UGT1A gene locus encodes 9 UGT1A proteins and contains four pseudogenes.

<p>The UGT1A gene locus encodes 9 UGT1A proteins and contains four pseudogenes.</p>
2
New cards

What is unique about Exon 1 in UGT1A isoforms?

Exon 1 is unique to each UGT1A isoform, while Exons 2-5 are shared by all isoforms.

3
New cards

What are some types of UGT polymorphisms?

UGT polymorphisms include TATA repeats and single nucleotide polymorphisms (SNPs).

4
New cards

What is Crigler-Najjar Syndrome?

Crigler-Najjar Syndrome is an inherited genetic disease resulting from the near complete loss of UGT1A1, leading to impaired bilirubin conjugation and hyperbilirubinemia.

5
New cards

What are the two types of Crigler-Najjar Syndrome?

Type I is a complete deficiency of UGT1A1 (most severe), while Type II is a near complete deficiency.

6
New cards

What are the symptoms associated with Crigler-Najjar Syndrome?

Symptoms include jaundice, potential for kernicterus, lethargy, increased muscle tone, and motor and intellectual disabilities.

7
New cards

How does light therapy help in Crigler-Najjar Syndrome?

Certain wavelengths of light (430-490 nm) convert bilirubin to water-soluble forms that can be eliminated.

8
New cards

What is Gilbert Syndrome?

Gilbert Syndrome occurs when only one copy of the UGT1A1 gene has a mutation, leading to a less severe increase in serum bilirubin levels.

9
New cards

What is the most common polymorphism associated with Gilbert Syndrome?

The most common polymorphism is the UGT1A1*28 allele.

10
New cards

What is the prevalence of Gilbert Syndrome in the US population?

Gilbert Syndrome affects approximately 5-10% of the US population, often in individuals of Asian descent.

11
New cards

What is Atazanavir and its effect on UGT1A1?

Atazanavir is an antiretroviral protease inhibitor that inhibits UGT1A1-glucuronidation of bilirubin, particularly in UGT1A1 poor metabolizers.

<p>Atazanavir is an antiretroviral protease inhibitor that inhibits UGT1A1-glucuronidation of bilirubin, particularly in UGT1A1 poor metabolizers.</p>
12
New cards

What is the consequence of UGT1A1 inhibition by Atazanavir?

Inhibition leads to indirect hyperbilirubinemia without hepatotoxicity, which may cause patients to discontinue treatment due to jaundice.

13
New cards

What is Irinotecan and its mechanism of action?

Irinotecan (CPT-11) is a prodrug used in chemotherapy that inhibits topoisomerase I, unwinding DNA during replication.

<p>Irinotecan (CPT-11) is a prodrug used in chemotherapy that inhibits topoisomerase I, unwinding DNA during replication.</p>
14
New cards

What is the role of UGT1A1 in the metabolism of SN-38?

UGT1A1 inactivates SN-38 to a glucuronide conjugate, which is crucial for its detoxification.

<p>UGT1A1 inactivates SN-38 to a glucuronide conjugate, which is crucial for its detoxification.</p>
15
New cards

What toxicities are associated with SN-38?

Toxicities include leukopenia, neutropenia, and intestinal cell damage leading to potentially life-threatening diarrhea.

16
New cards

How do UGT loss-of-function SNPs affect SN-38 toxicity?

Patients with Gilbert's or other UGT loss-of-function SNPs are at increased risk of SN-38 toxicities.

17
New cards

What are the acetylator genotypes associated with NAT2?

NAT2 genotypes include fast/rapid, intermediate, and poor/slow acetylators.

18
New cards

What is the risk for slow acetylators when taking isoniazid?

Slow acetylators are at increased risk of isoniazid-induced peripheral neuropathy.

<p>Slow acetylators are at increased risk of isoniazid-induced peripheral neuropathy.</p>
19
New cards

What can prevent isoniazid toxicity in slow acetylators?

Vitamin B6 (pyridoxine) can prevent isoniazid toxicity.

20
New cards

What is TPMT and its role in drug metabolism?

Thiopurine S-methyltransferase (TPMT) metabolizes thiopurines like 6-mercaptopurine, which are used in leukemia and inflammatory bowel disease.

<p>Thiopurine S-methyltransferase (TPMT) metabolizes thiopurines like 6-mercaptopurine, which are used in leukemia and inflammatory bowel disease.</p>
21
New cards

What is the significance of measuring TPMT activity?

TPMT activity is measured in RBCs as a surrogate for drug-metabolizing tissues, but is unreliable in patients who have received RBC transfusions recently.

22
New cards

What are the common alleles associated with TPMT activity?

TPMTH (high activity) includes 1 (wild-type) and 24, while TPMTL (low activity) includes 2, 3A, 3B, 3C, and *4.

23
New cards

What is the relationship between TPMT activity and 6-mercaptopurine toxicity?

Low TPMT activity is associated with increased toxicity from 6-mercaptopurine due to myelosuppression.

<p>Low TPMT activity is associated with increased toxicity from 6-mercaptopurine due to myelosuppression.</p>
24
New cards

What is the SEARCH study and its focus?

The SEARCH study examined the effectiveness of additional reductions in cholesterol and homocysteine, focusing on simvastatin and its association with myopathy.

25
New cards

What genetic variant is associated with simvastatin-induced myopathy?

A loss-of-function variant in OATP1B1 is associated with reduced hepatic uptake of simvastatin, leading to myopathy.

<p>A loss-of-function variant in OATP1B1 is associated with reduced hepatic uptake of simvastatin, leading to myopathy.</p>
26
New cards

What is the role of ABCG2 in gout?

SNPs in ABCG2 are associated with a higher risk of gout, particularly in males.

<p>SNPs in ABCG2 are associated with a higher risk of gout, particularly in males.</p>
27
New cards

What is the most common ABCG2 SNP associated with drug response?

The Q141K amino acid substitution in ABCG2 is associated with increased risk for gefitinib-induced diarrhea and altered pharmacokinetics.